Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$5.01M Buy
31,219
+629
+2% +$91.7K 0.39% 63
2023
Q3
$4.22M Buy
30,590
+2,775
+10% +$407K 0.39% 62
2023
Q2
$3.83M Buy
27,815
+2,005
+8% +$294K 0.35% 66
2023
Q1
$4.11M Sell
25,810
-1,537
-6% -$235K 0.44% 48
2022
Q4
$4.3M Buy
27,347
+10,899
+66% +$1.67M 0.71% 28
2022
Q3
$2.42M Buy
16,448
+1,175
+8% +$169K 1.03% 27
2022
Q2
$2.28M Sell
15,273
-116
-0.8% -$17.7K 1% 29
2022
Q1
$2.45M Sell
15,389
-282
-2% -$41K 0.96% 29
2021
Q4
$2.08M Sell
15,671
-1,098
-7% -$130K 0.87% 32
2021
Q3
$1.83M Buy
16,769
+438
+3% +$50K 0.69% 44
2021
Q2
$1.93M Buy
16,331
+1,467
+10% +$165K 0.73% 44
2021
Q1
$1.58M Buy
14,864
+944
+7% +$101K 0.67% 44
2020
Q4
$1.49M Buy
+13,920
New +$1.34M 0.69% 44
2019
Q4
Sell
-17,753
Closed -$1.3M 165
2019
Q3
$1.3M Buy
+17,753
New +$1.22M 1.08% 23
2019
Q2
Sell
-3,129
Closed -$259K 164
2019
Q1
$259K Buy
3,129
+36
+1% +$2.94K 0.28% 102
2018
Q4
$285K Buy
+3,093
New +$272K 0.38% 90

Other funds holding ABBV

DFPG Investments's ABBV Position: Q4 2023 in Review

DFPG Investments increased its AbbVie (ABBV) stake by 2.1% in Q4 2023, buying an estimated $91.7K and bringing the position to 31,219 shares worth $5.01M. The position accounts for 0.39% of the portfolio, ranked #63.

DFPG Investments first reported a position in ABBV in Q4 2018 and has held it in 16 quarters since. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • DFPG Investments held 31,219 shares of AbbVie worth $5.01M as of Q4 2023.
  • DFPG Investments bought 629 AbbVie shares in Q4 2023, an estimated $91.7K.
  • AbbVie made up 0.39% of DFPG Investments's portfolio in Q4 2023, its #63 holding.
  • DFPG Investments first reported a position in AbbVie in Q4 2018 and has held it in 16 quarters since.
  • 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.